Skip to content
PIL Logo

octagam 10%

Last Updated on eMC 11-Apr-2016 View document  | Octapharma Limited Contact details

When a pharmaceutical company changes an SPC or PIL, a new version is published on the eMC.  For each version, we show the dates it was published on the eMC and the reasons for change.

Updated on 11-Apr-2016 and displayed until Current

Reasons for adding or updating:

  • Change to section 1 - what the product is used for
  • Change to section 4 - possible side effects
  • Change to section 6 - date of revision
  • Improved presentation of PIL

Updated on 29-Jan-2016 and displayed until 11-Apr-2016

Reasons for adding or updating:

  • Change to section 4 - possible side effects
  • Change to section 6 - manufacturer
  • Change to section 6 - date of revision

Updated on 11-Feb-2015 and displayed until 29-Jan-2016

Reasons for adding or updating:

  • Change to section 5 - how to store
  • Change to section 6 - date of revision

Updated on 13-May-2014 and displayed until 11-Feb-2015

Reasons for adding or updating:

  • Change to section 1 - what the product is used for
  • Change to section 2 - what you need to know - warnings and precautions
  • Change to section 2 - use in children/adolescents
  • Change to section 2 - interactions with other medicines, food or drink
  • Change to section 2 - pregnancy, breast feeding and fertility
  • Change to section 2 - driving and using machines
  • Change to section 4 - possible side effects
  • Change to section 4 - how to report a side effect
  • Change to section 6 - what the product looks like and pack contents
  • Change to section 6 - date of revision
  • Removal of black triangle

Updated on 29-Jul-2011 and displayed until 13-May-2014

Reasons for adding or updating:

  • Unknown

Updated on 18-May-2009 and displayed until 29-Jul-2011

Reasons for adding or updating:

  • New PIL for eMC ie a PIL for an existing product but one that is new to the eMC

Company contact details

Octapharma Limited

Company image
Address

The Zenith Building, 26 Spring Gardens, Manchester, Lancashire, M2 1AB

Fax

+44 (0)161 837 3799

Medical Information e-mail
Telephone

+44 (0)161 837 3770

Medical Information Direct Line

0845 1300 522

Medical Information Fax

+44 (0)161 837 3799

Before you contact this company: often several companies will market medicines with the same active ingredient. Please check that this is the correct company before contacting them. Why?

Active ingredients

human normal immunoglobulin

Legal categories

POM - Prescription Only Medicine

This site uses cookies. By continuing to browse the site you are agreeing to our policy on the use of cookies. Continue